APA (7th ed.) Citation

Tsoi, H., Leung, G. M. H., Man, E. P. S., You, C. P., Cheung, K. H. L., Chan, K. Y. K., . . . Khoo, U. S. (2025). Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-06902-8

Chicago Style (17th ed.) Citation

Tsoi, Ho, George Man Hong Leung, Ellen Pui Sum Man, Chan Ping You, Koei Ho Lam Cheung, Kelvin Yuen Kwong Chan, Chun Gong, Michael Shing Yan Huen, and Ui Soon Khoo. "Ivabradine Induces RAD51 Degradation, Potentiating PARP Inhibitor Efficacy in Non-germline BRCA Pathogenic Variant Triple-negative Breast Cancer." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-06902-8.

MLA (9th ed.) Citation

Tsoi, Ho, et al. "Ivabradine Induces RAD51 Degradation, Potentiating PARP Inhibitor Efficacy in Non-germline BRCA Pathogenic Variant Triple-negative Breast Cancer." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-06902-8.